SEC Form 4 · accession 0001209191-16-130529
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Winnie Wing-Kei Tso
Officer — Chief Financial Officer
Period of report
Jun 30, 2016
Accepted (ET)
Jul 1, 2016 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.57 | Jun 30, 2016 | A | 14,000 | A | Jun 30, 2016 | Mar 22, 2026 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1On March 22, 2016, the reporting person was granted an option to purchase 17,500 shares of common stock. The option vests according to the following schedule: 80% vests upon the achievement of one performance milestone (the "First Milestone") and 20% vests upon the achievement of a second performance milestone. The First Milestone occurred on June 30, 2016, resulting in vesting of the option as to 14,000 shares.